Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-23T05:24:34.493Z Has data issue: false hasContentIssue false
  • English
  • Français

Ovarian Hyperstimulation Syndrome May be More Likely if Multiple Pregnancy Occurs Following Assisted Conception

Published online by Cambridge University Press:  01 August 2014

R. S. Mathur ,
L. A. Joels  and
J. M. Jenkins
R. S. Mathur
Affiliation:
University of Bristol, Department of Obstetrics & Gynaecology, St. Michael's Hospital, Bristol
L. A. Joels
Affiliation:
University of Bristol, Department of Obstetrics & Gynaecology, St. Michael's Hospital, Bristol
J. M. Jenkins
Affiliation:
University of Bristol, Department of Obstetrics & Gynaecology, St. Michael's Hospital, Bristol

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Whereas modern assisted conception with such techniques as in vitro fertilisation now helps many subfertile couples to fulfil their ambition to have a child, it has not been without a price. The increased incidence of multiple pregnancies, with their attendant maternal and perinatal sequelae following assisted conception is well known, but perinatologists may be less familiar with the Ovarian Hyperstimulation Syndrome (OHSS) which is the other major complication when controlled ovarian hyperstimulation is used during assisted conception treatment. Mild forms of OHSS are common and require no more than symptomatic treatment. Severe forms of OHSS are uncommon occurring in 0.6% to 14% of IVF cycles [15, 5], but are nonetheless very important to identify as they may lead to thrombo-embolic disease, cardiorespiratory dysfunction, renal failure and even death [6]. This review considers whether OHSS may be related to multiple pregnancy by reviewing the available literature and local experience.

Keywords

Ovarian Hyperstimulation SyndromeIn vitro fertilisationMultiple pregnancy
Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 44 , Issue 3-4 , October 1995 , pp. 233 - 235
Copyright
Copyright © The International Society for Twin Studies 1995

References

REFERENCES

1. Bergh, PA, Navot, D (1992): Ovarian Hyperstimulation Syndrome: A Review of Pathophysiology. J Asst Reprod Genet 9, 429–38.Google Scholar
2. Delvigne, A, Demoulin, A, Smitz, J, Donnez, J, Konninckx, P, Dhont, M, Englert, Y, Delbeke, L, Darcis, L, Gordts, S, Puttemans, P, Gerris, J, Schoysman, R, Leroy, F (1993): The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod 8, 1353–60.Google Scholar
3. Forman, RG, Frydman, R, Egan, D, Ross, C, Barlow, DH (1990): Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for invitro fertilisation: a European series and a proposal for prevention. Fertil Steril 53: 502.Google Scholar
4. Freidlander, MA, de Mola, JRL, Goldfarb, JM (1993): Elevated levels of interleukin-6 in ascites from women with ovarian hyperstimulation syndrome. Fertil Steril 60, 826–3.CrossRefGoogle Scholar
5. Herman, A, Ron-El, R, Golan, A, Raziel, A, Soffer, Y, Caspi, E (1990): Pregnancy rate and ovarian hyperstimulation after luteal chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. Fertil Steril 53, 92–6.Google Scholar
6. Jenkins, JM, Mathur, RS, Cooke, ID (1995): The management of severe ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 102, 2–5.Google Scholar
7. Lyons, CAD, Wheeler, CA, Frishman, GN, Hackett, RJ, Seifer, DB, Haning, RV Jr (1994): Early and late presentations of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 9, 792–9.Google Scholar
8. MacDougall, MJ, Tan, SL, Jacobs, HS (1992): ln-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 7, 597–600.CrossRefGoogle ScholarPubMed
9. Medical Research International and the Society for Assisted Reproductive Technology (1992): In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Fertil Steril 57, 15–24.CrossRefGoogle Scholar
10. Navot, D, Margalioth, EJ, Laufer, N, Birkenfeld, A, Relou, A, Rosler, A, Schenker, JG (1987): Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 48, 57–61.CrossRefGoogle ScholarPubMed
11. Navot, D, Bergh, PA, Laufer, N (1992): Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58, 249–61.Google Scholar
12. Rizk, B, Aboulghar, MA, Mansour, RT, Serour, GI, Amin, Y (1991): Severe ovarian hyperstimulation syndrome: analytical study of twenty-one cases. Hum Reprod 6 (Suppl): 368–9.Google Scholar
13. Schmidt, LL, Asch, RH, Frederick, JL, Rojas, FJ, Stone, SC, Balmaceda, JP (1994): Predictive value of a single beta human chorionic gonadotropin level in pregnancies achieved by assisted reproduction techniques. Fertil Steril 62, 333–8.Google Scholar
14. Sealey, JE, McCord, D, Taufield, PA, Ales, SA, Laragh, JH (1985): Plasma prorenin in first-trimester pregnancy: Relationship to changes in human chorionic gonadotropin. Am J Obstet Gynecol 153, 514–9.Google Scholar
15. Smitz, J, Camus, M, Devroey, P, Errard, P, Wisanto, A, van Steirteghem, AC (1990): Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/hMG superovulation for in-vitro fertilization. Hum Reprod 5, 933–7.Google Scholar